Paper35239126
Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models.
Yin W and 2 others. Lifetime Data Anal, 2022. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models. Papers, record 35239126. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35239126
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Algorithms | Major topic |
| Bayes Theorem | |
| Humans | |
| Survival Analysis |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15293631 | Estimating marginal effects in accelerated failure time models for serial sojourn times among repeated events. | Lifetime Data Anal | 2004 | https://conductscience.org/library/papers/15293631 | PubMed |
| 2 | 15737088 | Quantile regression models with multivariate failure time data. | Biometrics | 2005 | https://conductscience.org/library/papers/15737088 | PubMed |
| 3 | 26445238 | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma. | J Hematol Oncol | 2015 | https://conductscience.org/library/papers/26445238 | PubMed |
| 4 | 23475625 | Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. | Am J Hematol | 2013 | https://conductscience.org/library/papers/23475625 | PubMed |
| 5 | 26243050 | A permutation approach for selecting the penalty parameter in penalized model selection. | Biometrics | 2015 | https://conductscience.org/library/papers/26243050 | PubMed |
| 6 | 16984324 | Regularized estimation in the accelerated failure time model with high-dimensional covariates. | Biometrics | 2006 | https://conductscience.org/library/papers/16984324 | PubMed |
| 7 | 24549607 | Marginal semiparametric multivariate accelerated failure time model with generalized estimating equations. | Lifetime Data Anal | 2014 | https://conductscience.org/library/papers/24549607 | PubMed |
| 8 | 31586968 | Stability selection for lasso, ridge and elastic net implemented with AFT models. | Stat Appl Genet Mol Biol | 2019 | https://conductscience.org/library/papers/31586968 | PubMed |
| 9 | 30400837 | Bayesian variable selection for parametric survival model with applications to cancer omics data. | Hum Genomics | 2018 | https://conductscience.org/library/papers/30400837 | PubMed |
| 10 | 20013308 | Variable selection in the accelerated failure time model via the bridge method. | Lifetime Data Anal | 2010 | https://conductscience.org/library/papers/20013308 | PubMed |
| 11 | 17221306 | Tests of independence for censored bivariate failure time data. | Lifetime Data Anal | 2007 | https://conductscience.org/library/papers/17221306 | PubMed |
| 12 | 16188652 | Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma. | Hematology | 2005 | https://conductscience.org/library/papers/16188652 | PubMed |
| 13 | 31221779 | The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation. | Haematologica | 2020 | https://conductscience.org/library/papers/31221779 | PubMed |
| 14 | 24478569 | The Dantzig Selector for Censored Linear Regression Models. | Stat Sin | 2014 | https://conductscience.org/library/papers/24478569 | PubMed |
| 15 | 21484848 | On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. | Stat Med | 2011 | https://conductscience.org/library/papers/21484848 | PubMed |
| 16 | 10544310 | Linear regression for bivariate censored data via multiple imputation. | Stat Med | 1999 | https://conductscience.org/library/papers/10544310 | PubMed |
| 17 | 29121829 | Variable selection for accelerated lifetime models with synthesized estimation techniques. | Stat Methods Med Res | 2019 | https://conductscience.org/library/papers/29121829 | PubMed |
| 18 | 18573133 | Regularized estimation for the accelerated failure time model. | Biometrics | 2009 | https://conductscience.org/library/papers/18573133 | PubMed |
| 19 | 20037673 | A group bridge approach for variable selection. | Biometrika | 2009 | https://conductscience.org/library/papers/20037673 | PubMed |
| 20 | 16728703 | The molecular classification of multiple myeloma. | Blood | 2006 | https://conductscience.org/library/papers/16728703 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35239126
GET https://conductscience.org/api/papers/v1/35239126/references?page=2